Abstract
Two recent studies describe the largest molecular profiling analyses to date of clear-cell renal cell carcinoma (ccRCC) and report remarkably similar findings. The recurrent pathway alterations identified in these studies open new avenues for therapeutic advances in this chemotherapy- and radiation-resistant disease.
Original language | English |
---|---|
Pages (from-to) | 849-850 |
Number of pages | 2 |
Journal | Nature Genetics |
Volume | 45 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2013 |